On March 12, 2019 the U.S. Patent and Trademark Office issued U.S. Patent No. (‘the ‘611 patent), to The Regents of the University of California, the University of Vienna, and Dr. Emmanuelle Charpentier (collectively, “CVC”). The patent covers the use of single guide RNA formats in any setting. The ‘611 patent claims earliest priority to a U.S. provisional application, filed by CVC on May 25, 2012.
View Press Release